Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Literature
1.
Spagnolello O, Letteri F, Falcou A, Cipollone L, De Michele M, Bertazzoni G, Toni D (2019) Dabigatran reversal with Idarucizumab in an emergency lumbar puncture: a case report. Curr Drug Saf 14(1):40–42CrossRefPubMed
2.
Braemswig TB, Eschenfelder CC, Nolte CH (2017) Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab. Am J Emerg Med 35:662.e3–662.e4CrossRef
3.
Vosko MR, Bocksrucker C, Drwila R, Dulicek P, Hauer T et al (2017) Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases. J Thromb Thrombolysis 43:306–317CrossRefPubMedPubMedCentral
4.
Agosti S, Casalino L, Daffonchio A, Arena L, Celli L, Rota E (2018) Emergency lumbar puncture for suspected meningitis after dabigatran reversal with idarucizumab: a case report. J Clin Case Rep 8:4
5.
Dodd KC, Emsley HCA, Desborough MJR, Chhetri SK (2018) Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists clinical guideline. Pract Neurol 18(6):436–446CrossRefPubMed
6.
Rota E, Agosti S, Risso R, Morelli N (2018) Lumbar puncture on Direct Oral Anticoagulants (DOACs): a novel, emerging perspective. Published on: 1 October 2018. Response to: Dodd KC, Emsley HCA, Desborough MJR, Chhetri SK (2018) Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists clinical guideline. Pract Neurol 18(6):436-446CrossRefPubMed
7.
Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H, ESC Scientific Document Group (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330–1393CrossRefPubMed
8.
Touzé E, Gruel Y, Gouin-Thibault I, De Maistre E, Susen S, Sie P, Derex L (2018) Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants. Expert opinion of the Societé Francaise de Neurologie Vasculaire (SFNV) and the Groupe Francais d'etudes sur l'Hemostase et la Thrombose (GFHT). Eur J Neurol. https://​doi.​org/​10.​1111/​ene.​13582 CrossRefPubMed
9.
Seiffge DJ, Traenka C, Polymeris AA, Thilemann S, Wagner B, Hert L, Müller MD, Gensicke H, Peters N, Nickel CH, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis GM, Lyrer PA, Bonati LH, Tsakiris DA, Engelter ST (2017) Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice. J Stroke 19(3):347–355CrossRefPubMedPubMedCentral
10.
Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM, Wirth D, Kaatz S (2019) Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol 94:697–709CrossRefPubMed
11.
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22):2864–2870CrossRefPubMed
12.
Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJ, Lip GY (2010) A Novel User-Friendly Score (HAS-BLED) to Assess 1-Year Risk of Major Bleeding in Patients with Atrial Fibrillation. Chest 138(5):1093–1100CrossRefPubMed
13.
Hostler DC, Marx ES, Moores LK, Petteys SK, Hostler JM, Mitchell JD, Holley PR, Collen JF, Foster BE, Holley AB (2016) Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) bleeding risk score. Chest 149:372–379CrossRefPubMed
Metadata
Title
Lumbar puncture after direct oral anticoagulant (DOAC) reversal: a proposed algorithm for the emergency department
Authors
Eugenia Rota
Sergio Agosti
Roberta Risso
Nicola Morelli
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 7/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02162-9

Other articles of this Issue 7/2019

Internal and Emergency Medicine 7/2019 Go to the issue

IM - ORIGINAL

Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

IM - CASE RECORD

A sweet fever

IM - ORIGINAL

Endothelin-1 in hypertensive patients with ischemic heart disease

Points of View

Why include the humanities in medical studies?

IM - Commentary

Atrial fibrillation and kidney disease: insights on a close relationship

EM - ORIGINAL

Diagnostic imaging for acute abdominal pain in an Emergency Department in Italy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits